𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Nicardipine in the treatment of raynaud's

✍ Scribed by André Kahan; Bernard Amor; Charles J. Menkès

Publisher
John Wiley and Sons
Year
1987
Tongue
English
Weight
236 KB
Volume
30
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy of intracoronary nicardipine in
Efficacy of intracoronary nicardipine in the treatment of no-reflow during percutaneous coronary intervention
✍ Raymond I. Huang; Parul Patel; Paul Walinsky; David L. Fischman; J. David Ogilby 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB 👁 2 views

## Abstract Objectives: The goal of this study was to evaluate the safety and efficacy of nicardipine in reversing no‐reflow during percutaneous coronary intervention (PCI). Background: No‐reflow is a common complication of PCI in patients with acute coronary syndromes or venous bypass graft diseas

The clinical significance of raynaud's p
The clinical significance of raynaud's phenomenon in systemic lupus erythematosus
✍ Jacob Dimant; Ellen Ginzler; Michael Schlesinger; Gary Sterba Herbert Diamond; D 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 English ⚖ 371 KB 👁 1 views

## Abstract In a prospective study of 226 patients with systemic lupus erythematosus (SLE), 91 patients (40%) had Raynaud's phenomenon. These patients were compared to 135 patients without Raynaud's phenomenon. Patients with Raynaud's phenomenon had a greater incidence of arthritis (__P__ < 0.02),